Technical approaches for mouse models of human disease
- PMID: 21558063
- PMCID: PMC3097452
- DOI: 10.1242/dmm.000901
Technical approaches for mouse models of human disease
Abstract
The mouse is the leading organism for disease research. A rich resource of genetic variation occurs naturally in inbred and special strains owing to spontaneous mutations. However, one can also obtain desired gene mutations by using the following processes: targeted mutations that eliminate function in the whole organism or in a specific tissue; forward genetic screens using chemicals or transposons; or the introduction of exogenous transgenes as DNAs, bacterial artificial chromosomes (BACs) or reporter constructs. The mouse is the only mammal that provides such a rich resource of genetic diversity coupled with the potential for extensive genome manipulation, and is therefore a powerful application for modeling human disease. This poster review outlines the major genome manipulations available in the mouse that are used to understand human disease: natural variation, reverse genetics, forward genetics, transgenics and transposons. Each of these applications will be essential for understanding the diversity that is being discovered within the human population.
Figures
Similar articles
-
Chemical mutagens, transposons, and transgenes to interrogate gene function in Drosophila melanogaster.Methods. 2014 Jun 15;68(1):15-28. doi: 10.1016/j.ymeth.2014.02.025. Epub 2014 Feb 28. Methods. 2014. PMID: 24583113 Free PMC article. Review.
-
Transposon mutagenesis in mice.Methods Mol Biol. 2009;530:379-90. doi: 10.1007/978-1-59745-471-1_20. Methods Mol Biol. 2009. PMID: 19266336 Free PMC article.
-
[Applications of DNA transposons to the study of gene function in mice].Yi Chuan. 2011 May;33(5):485-93. doi: 10.3724/sp.j.1005.2011.00485. Yi Chuan. 2011. PMID: 21586395 Review. Chinese.
-
Genetic approaches to studying mouse models of human seizure disorders.Adv Exp Med Biol. 2004;548:1-11. doi: 10.1007/978-1-4757-6376-8_1. Adv Exp Med Biol. 2004. PMID: 15250582 Review.
-
Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.Semin Cell Dev Biol. 2014 Mar;27:86-95. doi: 10.1016/j.semcdb.2014.01.006. Epub 2014 Jan 24. Semin Cell Dev Biol. 2014. PMID: 24468652 Free PMC article. Review.
Cited by
-
Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering.Nucleic Acids Res. 2023 May 9;51(10):5285-97. doi: 10.1093/nar/gkad366. Online ahead of print. Nucleic Acids Res. 2023. PMID: 37158248 Free PMC article.
-
The Mouse Models of Human Cancer database (MMHCdb).Dis Model Mech. 2023 Apr 1;16(4):dmm050001. doi: 10.1242/dmm.050001. Epub 2023 Apr 14. Dis Model Mech. 2023. PMID: 36967676 Free PMC article.
-
Neural probe system for behavioral neuropharmacology by bi-directional wireless drug delivery and electrophysiology in socially interacting mice.Nat Commun. 2022 Sep 21;13(1):5521. doi: 10.1038/s41467-022-33296-8. Nat Commun. 2022. PMID: 36130965 Free PMC article.
-
Acute systemic knockdown of Atg7 is lethal and causes pancreatic destruction in shRNA transgenic mice.Autophagy. 2022 Dec;18(12):2880-2893. doi: 10.1080/15548627.2022.2052588. Epub 2022 Mar 28. Autophagy. 2022. PMID: 35343375 Free PMC article.
-
Transgenic Model Systems Have Revolutionized the Study of Disease.DNA Cell Biol. 2022 Jan;41(1):49-52. doi: 10.1089/dna.2021.0514. Epub 2021 Dec 23. DNA Cell Biol. 2022. PMID: 34941457 Free PMC article.
References
-
- Bestor T. H. (2005). Transposons reanimated in mice. Cell 122, 322–325 - PubMed
-
- Beutler B., Du X., Xia Y. (2007). Precis on forward genetics in mice. Nat. Immunol. 8, 659–664 - PubMed
-
- Branda C. S., Dymecki S. M. (2004). Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6, 7–28 - PubMed
-
- Capecchi M. R. (1989). The new mouse genetics: altering the genome by gene targeting. Trends Genet. 5, 70–76 - PubMed
-
- Carpinelli M. R., Hilton D. J., Metcalf D., Antonchuk J. L., Hyland C. D., Mifsud S. L., Di Rago L., Hilton A. A., Willson T. A., Roberts A. W., et al. (2004). Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl. Acad. Sci. USA 101, 6553–6558 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources